Czech National Bank Dexcom Inc Transaction History

Czech National Bank

$12.5 Billion
Q2 2025

A detailed history of Czech National Bank transactions in Dexcom Inc stock. As of the latest transaction made, Czech National Bank holds 95,845 shares of DXCM stock, worth $8.13 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

95,845

Previous 89,737 6.81%

Holding current value

$8.13 Million

Previous $6.13 Million 36.52%

% of portfolio

0.07%

Previous 0.06%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	BUY	$59.83 - $87.57 $365,441 - $534,877	6,108 Added 6.81%	95,845 $8.37 Million
Q1 2025 Apr 09, 2025	BUY	$67.74 - $90.75 $341,951 - $458,106	5,048 Added 5.96%	89,737 $6.13 Million
Q4 2024 Jan 13, 2025	BUY	$65.68 - $81.01 $200,783 - $247,647	3,057 Added 3.74%	84,689 $6.59 Million
Q3 2024 Oct 03, 2024	BUY	$64.0 - $116.06 $374,400 - $678,951	5,850 Added 7.72%	81,632 $5.47 Million
Q2 2024 Jul 15, 2024	BUY	$110.31 - $140.45 $877,074 - $1.12 Million	7,951 Added 11.72%	75,782 $8.59 Million
Q1 2024 Apr 10, 2024	BUY	$114.22 - $140.1 $18,275 - $22,416	160 Added 0.24%	67,831 $9.41 Million
Q4 2023 Jan 08, 2024	SELL	$75.49 - $124.16 $9,134 - $15,023	-121 Reduced 0.18%	67,671 $8.4 Million
Q3 2023 Oct 19, 2023	BUY	$86.06 - $137.93 $1.89 Million - $3.02 Million	21,904 Added 47.73%	67,792 $6.32 Million
Q2 2023 Jul 11, 2023	BUY	$112.47 - $130.98 $38,239 - $44,533	340 Added 0.75%	45,888 $5.9 Million
Q1 2023 Apr 17, 2023	BUY	$104.0 - $122.92 $34,944 - $41,301	336 Added 0.74%	45,548 $5.29 Million
Q4 2022 Jan 18, 2023	SELL	$84.98 - $122.67 $35,011 - $50,540	-412 Reduced 0.9%	45,212 $0
Q3 2022 Oct 31, 2022	BUY	$76.35 - $94.18 $3.48 Million - $4.3 Million	45,624 New	45,624 $3.68 Million

Others Institutions Holding DXCM

# of Institutions

1,086

Shares Held

363M

Call Options Held

5.4M

Put Options Held

4.3M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $32.8B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Czech National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Czech National Bank with notifications on news.

Account

Czech National Bank Dexcom Inc Transaction History